Literature DB >> 28750418

Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection.

Ulrich Güller1, Rene Warschkow2, Christoph Jakob Ackermann3, Bruno Schmied2, Thomas Cerny3, Silvia Ess4.   

Abstract

BACKGROUND: In various countries, the association of lower hospital volume and higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection has been clearly demonstrated. However, scientific evidence regarding the volume-outcomes relationship for high-risk visceral surgical procedures in Switzerland is lacking. The a priori hypothesis of this retrospective population-based cohort study analysis was that low-volume hospitals in Switzerland have a higher rate of postoperative mortality after oesophageal, gastric, pancreatic and rectal cancer resection.
METHODS: Patients undergoing elective resection of oesophageal, gastric, pancreatic and rectal cancer between 1999 and 2012 were identified in the inpatient database of the Swiss Federal Statistical Office. Nonparametric correlation analyses were used to assess time trends. Mortality was assessed in univariable and risk-adjusted conditional logistic regression analyses with stratification for year of surgery.
RESULTS: A total of 1487 oesophageal, 4404 gastric, 2668 pancreatic and 9743 rectal cancer patients were identified. For all cancer entities, significant treatment centralisation was observed over the time period (all p <0.001). The rate of mortality was inversely related to the annual number of patients treated at a certain hospital. The decrease of postoperative mortality from low-volume to high-volume hospitals was 6.3% to 3.3% for oesophageal cancer (p = 0.019), 4.9% to 3.3% for gastric cancer (p = 0.023), 5.4% to 2.0% for pancreatic cancer (p = 0.037), and 2.4% to 1.6% for rectal cancer (p = 0.008). These results were confirmed in risk-adjusted analyses with a decreased odds of pos-operative death by 49% for oesophageal (odds ratio [OR] 0.51, 95% confidence interval [CI] 0.22-1.18; p = 0.085), 32% for gastric (OR 0.68, 95% CI 0.48-0.98; p = 0.032), 68% for pancreatic (OR 0.32, 95% CI 0.11-0.89; p = 0.011) and 29% for rectal cancer (OR 0.71, 95% CI 0.52-0.98; p = 0.033).
CONCLUSION: This population-based analysis - the first of its kind in the literature - demonstrates a higher postoperative mortality in low-volume hospitals for patients undergoing oesophageal, gastric, pancreatic and rectal cancer resection in Switzerland. Hence, such operations should preferably be performed in high-volume hospitals.

Entities:  

Mesh:

Year:  2017        PMID: 28750418     DOI: 10.4414/smw.2017.14473

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  12 in total

1.  Centralization of Pancreatic Surgery in Europe.

Authors:  Adam Polonski; Jakob R Izbicki; Faik G Uzunoglu
Journal:  J Gastrointest Surg       Date:  2019-04-29       Impact factor: 3.452

2.  Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan; Haibo Wang
Journal:  Chin J Cancer Res       Date:  2021-12-31       Impact factor: 5.087

3.  Trends in pancreatic surgery in Switzerland: a survey and nationwide analysis over two decades.

Authors:  Christoph Kuemmerli; Marcel André Schneider; Gaëtan-Romain Joliat; Beat Moeckli; Kristjan Ukegjini; Martin Bolli; Mathias Worni; Dominique Lisa Birrer
Journal:  Langenbecks Arch Surg       Date:  2022-09-17       Impact factor: 2.895

Review 4.  Associations of Annual Hospital and Surgeon Volume with Patient Outcomes After Gastrectomy: A Systematic Review and Meta-analysis.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan
Journal:  Ann Surg Oncol       Date:  2022-09-15       Impact factor: 4.339

5.  The Impact of Hospital Level of Care on the Management of Acute Cholecystitis: a Population-Based Study.

Authors:  Lisa Lindqvist; Andreas Andersson; Johanna Österberg; Gabriel Sandblom; Oskar Hemmingsson; Pär Nordin; Lars Enochsson
Journal:  J Gastrointest Surg       Date:  2022-10-17       Impact factor: 3.267

Review 6.  Mortality factors in pancreatic surgery: A systematic review. How important is the hospital volume?

Authors:  Richard Hunger; Barbara Seliger; Shuji Ogino; Rene Mantke
Journal:  Int J Surg       Date:  2022-05-04       Impact factor: 13.400

7.  Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.

Authors:  Rene Warschkow; Catherine Tsai; Nastassja Köhn; Suna Erdem; Bruno Schmied; Daniel P Nussbaum; Beat Gloor; Sascha A Müller; Dan Blazer; Mathias Worni
Journal:  Langenbecks Arch Surg       Date:  2020-02-10       Impact factor: 3.445

8.  Chemoradiotherapy With or Without Surgery for Esophageal Squamous Cancer According to Hospital Volume.

Authors:  Mateus Bringel Oliveira Duarte; Eduardo Baldon Pereira; Luiz Roberto Lopes; Nelson Adami Andreollo; José Barreto Campello Carvalheira
Journal:  JCO Glob Oncol       Date:  2020-06

9.  When Team Conflicts Threaten Quality of Care: A Study of Health Care Professionals' Experiences and Perceptions.

Authors:  Stéphane Cullati; Naike Bochatay; Fabienne Maître; Thierry Laroche; Virginie Muller-Juge; Katherine S Blondon; Noëlle Junod Perron; Nadia M Bajwa; Nu Viet Vu; Sara Kim; Georges L Savoldelli; Patricia Hudelson; Pierre Chopard; Mathieu R Nendaz
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-02-26

Review 10.  [Treatment reality of aortic diseases in Switzerland].

Authors:  L Meuli; T Lattmann
Journal:  Gefasschirurgie       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.